Insights On Upstream Manufacturing

  1. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

  2. Achieving Rapid, High-Titer Expression For Next-Generation Biologics 3/24/2026

    Uncover how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.

  3. Biocapacitance Measurement: A PAT Tool For Biomass Measurement In An Upstream Process 3/20/2026

    Leverage process analytical technologies (PAT) to gain real-time insight into product quality, strengthen control strategies, and build more efficient, scalable manufacturing processes for future success.

  4. A Cell Line Development Platform Accelerating Timelines To Clinic 3/20/2026

    To support a seamless transition from early clinical studies through to commercial manufacturing, cell line expression systems must be carefully designed and selected based on several critical attributes.

  5. LVV Manufacturing: Old But Gold Gene Therapy Viruses? 3/20/2026

    Discover how plasmid design, transfection protocols, and controlled freezing methods combine to address critical manufacturing challenges in lentiviral vector production for gene therapy applications.

  6. Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development 3/19/2026

    Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.

  7. Licensed Vs. Unlicensed Cell Lines In Biologics Development 3/19/2026

    Choosing licensed vs. unlicensed cell lines impacts development speed, cost, flexibility, and long‑term control, making early strategic evaluation key to efficient biologics development.

  8. Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems 3/18/2026

    Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.

  9. In Vitro Transcription For mRNA Production 3/13/2026

    Efficient mRNA production relies on optimized IVT conditions, where NTPs, enzymes, and critical additives work together. Explore how the right components strengthen mRNA synthesis at every step.

  10. Go Beyond Custom Media Screening And Prototyping 3/13/2026

    Learn about manufacturing solutions that streamline cell culture media scale-up with global production capabilities, equivalency strategies, and quality assurance for reliable supply.